Oppenheimer reiterated coverage on Medtronic with a new price target

8/21/24 7:55:37 AM ET

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Health Care

Oppenheimer reiterated coverage of Medtronic with a rating of Perform and set a new price target of $94.00 from $92.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$MDT

Date	Price Target	Rating	Analyst
6/16/2025	$110.00	Outperform	Leerink Partners
3/4/2025	$92.00 → $107.00	Neutral → Buy	Citigroup
10/10/2024	$98.00 → $105.00	Sector Perform → Outperform	RBC Capital Mkts
8/21/2024	$92.00 → $94.00	Perform	Oppenheimer
8/15/2024	$76.00 → $90.00	Sell → Neutral	UBS
8/14/2024	$100.00 → $85.00	Buy → Hold	Stifel
5/30/2024	$83.00	Sell	Goldman
7/19/2023	$90.00	Neutral	Robert W. Baird